基本信息
文件名称:NLRP3-IN-73-生命科学试剂-MCE.pdf
文件大小:461.99 KB
总页数:1 页
更新时间:2025-05-22
总字数:约2.2千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

NLRP3-IN-73

Cat.No.:HY-173209

分?式:C??H??FN?O?

分?量:443.47

作?靶点:NOD-likeReceptor(NLR)

作?通路:Immunology/Inflammation

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性NLRP3-IN-73(W16)是?种可?服的、NLRP3炎症?体的组装抑制剂,对NLRP3/IL-1β通路的IC50值为0.18

μM。

体外研究NLRP3-IN-73(W16)dose-dependentlyinhibitsthereleaseofIL-1βinJ774A.1,BMDMsandhuman

peripheralbloodcells[1].

体内研究NLRP3-IN-73(W16:7.5mg/kg,15mg/kg,and30mg/kg,orally)haspotentanti-inflammatoryeffectson

DSS-inducedulcerativecolitismodel[1].

REFERENCES

[1].RuiwenWu,etal.Discovery,synthesis,andbiologicalmechanismevaluationofnovelquinolinederivativesaspotentNLRP3inhibitors.

EurJMedChem.2025May5:289:117466.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021-58955